FDA asks Abbott for another 30 days for its decision
This article was originally published in Clinica
The FDA has asked for a further 30-day extension to make its decision on whether Abbott's Lake County diagnostics site conforms to the Quality System Regulation. The FDA had already extended its review period by 45 days in March. The company now expects the FDA to give its answer in mid-May.